O Chosidow

Summary

Country: France

Publications

  1. ncbi Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease?
    O Chosidow
    Department of Internal Medicine, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie Salpetriere, Universite Paris VI, France
    Arch Dermatol 136:521-4. 2000
  2. ncbi Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial
    O Chosidow
    Department of Internal Medicine, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie Salpetriere, Universite Paris VI, 47 83 boulevard de l Hopital, France
    Br J Dermatol 148:142-6. 2003
  3. ncbi Cloxacillin versus pristinamycin for superficial pyodermas: a randomized, open-label, non-inferiority study
    O Chosidow
    Department of Internal Medicine, Hopital Pitie Salpetriere, Assistance Publique Hôpitaux de Paris and Université Paris VI, France
    Dermatology 210:370-4. 2005
  4. ncbi [Local corticosteroid therapy in dermatology]
    O Chosidow
    Service de Medecine Interne, Groupe Hospitalier Pitie Salpetriere, Paris
    Presse Med 28:2050-6. 1999
  5. ncbi Scabies and pediculosis
    O Chosidow
    Department of Internal Medicine, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitié Salêtrière, France
    Lancet 355:819-26. 2000
  6. ncbi Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis
    O Chosidow
    Department of Internal Medicine, Hopital Pitie Salpetriere, Paris, France
    Dermatology 206:233-40. 2003
  7. ncbi Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial
    O Chosidow
    Department of Internal Medicine, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie Salpetriere, Universite Paris VI, 47 83 Bd de l Hopital, 75013 Paris, France
    Br J Dermatol 144:818-24. 2001
  8. ncbi [Local treatments using antiviral and non-antiviral drugs for herpes facialis and genitalis (excluding pregnant females and neonates at risk)]
    O Chosidow
    , Groupe Hospitalier Pitie-Salpetriere, Paris, France
    Ann Dermatol Venereol 129:635-45. 2002
  9. ncbi [Herpes zoster: incidence study among "sentinel" general practitioners]
    S Czernichow
    , , Paris, France
    Ann Dermatol Venereol 128:497-501. 2001
  10. ncbi [Topical corticosteroids]
    B Lebrun-Vignes
    Service de Pharmacologie, Centre de Pharmacovigilance, Groupe Hospitalier Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris
    Ann Dermatol Venereol 131:39-48. 2004

Collaborators

Detail Information

Publications33

  1. ncbi Bullous pemphigoid and amyotrophic lateral sclerosis: a new clue for understanding the bullous disease?
    O Chosidow
    Department of Internal Medicine, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie Salpetriere, Universite Paris VI, France
    Arch Dermatol 136:521-4. 2000
    ..Isolated cases of BP in patients with other neurological disorders further support a pathogenic association between cutaneous and neurological diseases. Any description of BP in patients with amyotrophic lateral sclerosis is lacking...
  2. ncbi Valaciclovir as a single dose during prodrome of herpes facialis: a pilot randomized double-blind clinical trial
    O Chosidow
    Department of Internal Medicine, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie Salpetriere, Universite Paris VI, 47 83 boulevard de l Hopital, France
    Br J Dermatol 148:142-6. 2003
    ..Randomized clinical trials of valaciclovir in recurrent herpes labialis are lacking...
  3. ncbi Cloxacillin versus pristinamycin for superficial pyodermas: a randomized, open-label, non-inferiority study
    O Chosidow
    Department of Internal Medicine, Hopital Pitie Salpetriere, Assistance Publique Hôpitaux de Paris and Université Paris VI, France
    Dermatology 210:370-4. 2005
    ..Superficial pyodermas may require systemic antibiotics. In a previous open-label trial, oxacillin and pristinamycin achieved similar cure rates, but its design was not truly that of a non-inferiority study...
  4. ncbi [Local corticosteroid therapy in dermatology]
    O Chosidow
    Service de Medecine Interne, Groupe Hospitalier Pitie Salpetriere, Paris
    Presse Med 28:2050-6. 1999
    ..Cremes provide good cosmetic satisfaction. The number of tubes to be used must be strictly controlled. Occlusion is indicated in case of palmo-plantar or the scalp involvement...
  5. ncbi Scabies and pediculosis
    O Chosidow
    Department of Internal Medicine, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitié Salêtrière, France
    Lancet 355:819-26. 2000
    ..Moreover, definitive parasitic diagnosis can be difficult to obtain, and the value of new techniques remains to be confirmed. Difficulties in management have returned scabies and pediculosis to the limelight...
  6. ncbi Randomized, open-labeled, non-inferiority study between ciclopiroxolamine 1% cream and ketoconazole 2% foaming gel in mild to moderate facial seborrheic dermatitis
    O Chosidow
    Department of Internal Medicine, Hopital Pitie Salpetriere, Paris, France
    Dermatology 206:233-40. 2003
    ..In a placebo-controlled, double-blind clinical study, we demonstrated that antifungal ciclopiroxolamine (CIC) 1% cream was effective in mild to moderate facial seborrheic dermatitis...
  7. ncbi Famciclovir vs. aciclovir in immunocompetent patients with recurrent genital herpes infections: a parallel-groups, randomized, double-blind clinical trial
    O Chosidow
    Department of Internal Medicine, Assistance Publique Hopitaux de Paris, Groupe Hospitalier Pitie Salpetriere, Universite Paris VI, 47 83 Bd de l Hopital, 75013 Paris, France
    Br J Dermatol 144:818-24. 2001
    ..Twice-daily therapy with famciclovir (FCV) was shown to be effective for episodic therapy for recurrent genital herpes in a large placebo-controlled trial. However, no study has been published to date comparing FCV and aciclovir (ACV)...
  8. ncbi [Local treatments using antiviral and non-antiviral drugs for herpes facialis and genitalis (excluding pregnant females and neonates at risk)]
    O Chosidow
    , Groupe Hospitalier Pitie-Salpetriere, Paris, France
    Ann Dermatol Venereol 129:635-45. 2002
  9. ncbi [Herpes zoster: incidence study among "sentinel" general practitioners]
    S Czernichow
    , , Paris, France
    Ann Dermatol Venereol 128:497-501. 2001
    ..To be interpreted, this estimation has to be discussed according to the sample of population that was studied and the representativity of the "Sentinelles" general practitioners who participated the survey...
  10. ncbi [Topical corticosteroids]
    B Lebrun-Vignes
    Service de Pharmacologie, Centre de Pharmacovigilance, Groupe Hospitalier Pitie Salpetriere, 47 83, Boulevard de l Hopital, 75013 Paris
    Ann Dermatol Venereol 131:39-48. 2004
    ..and of its mode of application (technique, rhythm of application) is oriented by the context (dermatitis treated, localization) and must respect "Good clinical practice" guidelines so as to select the best benefit/risk ratio...
  11. ncbi [Cutaneous adverse drug reaction with pulmonary involvement]
    P Wolkenstein
    Service de Dermatologie, Hopital Henri Mondor, Creteil, France
    Rev Mal Respir 20:719-26. 2003
    ..Cutaneous adverse drug reactions can be life-threatening: toxic necrolis and hypersensitivity syndrome or DRESS ("Drug Rash with Eosinophilia and Systemic Symptoms")...
  12. ncbi Clinical pharmacokinetics of mizolastine
    B Lebrun-Vignes
    Department of Dermatology, Bichat Claude Bernard Hospital and School of Medicine, University of Paris VII, France
    Clin Pharmacokinet 40:501-7. 2001
    ..No direct relationship was found between drug concentrations in skin blister fluid and antihistamine activity...
  13. ncbi [Frequency of plantar dermatophytosis. A retrospective study 2002-2003]
    F Foulet
    Service de Parasitologie Mycologie, Hopital Henri Mondor, AP HP, Creteil
    Ann Dermatol Venereol 134:343-5. 2007
    ..The purpose of this study was to evaluate the incidence of plantar dermatophytosis in association with onyxis and intertrigo involving dermatophytes...
  14. ncbi Recurrent erysipelas: 47 cases
    S Leclerc
    Department of Internal Medicine, Hopital de la Pitie Salpetriere, AP HP, Universite Pierre et Marie Curie Paris 6, Paris, France
    Dermatology 214:52-7. 2007
    ..Recurrence is a common complication of erysipelas (cellulitis)...
  15. ncbi Melkersson-Rosenthal syndrome and acquired C1 inhibitor deficiency
    F Masson
    Department of Dermatology and Allergy, Tenon Hospital, Paris, France
    Dermatology 217:114-20. 2008
    ..Melkersson-Rosenthal syndrome (MRS) is a rare disease whose full-blown form is characterized by orofacial swelling, facial palsy and lingua plicata...
  16. ncbi [Atypical recurrent aseptic cutaneous abscesses as the presenting manifestation of Crohn's disease]
    T A Szwebel
    Service de Medecine Interne, Universite Paris Descartes, Hotel Dieu, AP HP, 75004 Paris, France
    Rev Med Interne 31:705-8. 2010
    ..We report here a case of chronic inflammatory bowel disease revealed by multiple large cutaneous aseptic distal necrotic ulcers...
  17. ncbi Severe perturbations of the blood T cell repertoire in polymyositis, but not dermatomyositis patients
    O Benveniste
    , , and Laboratoire de Neuropathologie, , Paris, France
    J Immunol 167:3521-9. 2001
    ..Moreover, this method may be helpful for the differential diagnosis of polymyositis and dermatomyositis and for noninvasive follow-up of polymyositis patients...
  18. ncbi Neutrophilic dermatoses during granulocytopenia
    S Aractingi
    Department of Dermatology, Hopital Saint Louis, Paris, France
    Arch Dermatol 131:1141-5. 1995
    ..We undertook a retrospective study of the neutrophilic dermatoses that developed during granulocytopenia induced by chemotherapy for acute myelogenous leukemia...
  19. ncbi Acute hepatitis during hypersensitivity syndrome due to midecamycin
    T Thevenot
    Service d Hepato Gastroenterologie, Groupe Hospitalier Pitie Salpetriere, Paris, France
    Eur J Gastroenterol Hepatol 9:1249-50. 1997
    ..Liver eosinophil polynuclear infiltrate, hypereosinophilia and acute interstitial nephritis were consistent with the hypothesis of an immunoallergic mechanism...
  20. ncbi [Skin signs associated with epidermal growth factor inhibitors]
    S Hannoud
    Service de Medecine Interne, AP HP et Université Paris VI, Groupe Hospitalier Pitie Salpetriere, 47, Boulevard de l Hopital, 750I3 Paris
    Ann Dermatol Venereol 133:239-42. 2006
    ..Adverse cutaneous effects of these drugs are now starting to be described...
  21. ncbi [Prescription and surveillance of steroidal and non-steroidal anti-inflammatory agents. Prescription and surveillance of a dermocorticoid treatment]
    J M Bonnetblanc
    Ann Dermatol Venereol 129:S157-61. 2002
  22. ncbi Superficial pyodermas: advances, recommendations and needs
    P Del Giudice
    Dermatology 210:367-9. 2005
  23. ncbi Lithium gluconate 8% vs ketoconazole 2% in the treatment of seborrhoeic dermatitis: a multicentre, randomized study
    B Dreno
    Clinique Dermatologique, CHU Nantes, Hotel Dieu, BP 1005, 44305 Nantes Cedex, France
    Br J Dermatol 148:1230-6. 2003
    ..Objectives This randomized controlled trial was designed to show a non-inferiority of 15% (primary end-point) of lithium gluconate 8% ointment compared with ketoconazole 2% emulsion...
  24. ncbi Superpotent topical steroid therapy for epidermolysis bullosa acquisita
    S Abecassis
    Dermatology 209:164-6. 2004
  25. ncbi [French National Authority for Health (HAS) report on changes in recommended bandaging practice for acute and chronic wounds. How and why? Principal results and practical consequences]
    G Chaby
    Ann Dermatol Venereol 135:441-5. 2008
  26. ncbi [Diffuse cholesterol embolism after fibrinolysis for myocardial infarction]
    G Pochmalicki
    Service de cardiologie, , Provins
    Arch Mal Coeur Vaiss 86:263-6. 1993
    ..This case (fifth reported case) of multiple cholesterol embolisation from the abdominal aorta caused by thrombolysis is the earliest presentation of this complication in the literature...
  27. ncbi Efficacy and safety of retapamulin ointment as treatment of impetigo: randomized double-blind multicentre placebo-controlled trial
    S Koning
    Department of General Practice, Erasmus MC University Medical Center Rotterdam, PO Box 2040, 3000 CA Rotterdam, The Netherlands
    Br J Dermatol 158:1077-82. 2008
    ..Worldwide, resistance rates of S. aureus against commonly used antibiotics are rising. Retapamulin belongs to a newly developed class of antibiotics for the treatment of uncomplicated skin infections...
  28. ncbi [Systemic corticosteroids]
    O Chosidow
    , , , 4, rue de la Chine, 75020 Paris
    Ann Dermatol Venereol 134:942-8. 2007
  29. ncbi Clinical criteria for the diagnosis of bullous pemphigoid: a reevaluation according to immunoblot analysis of patient sera
    P Joly
    Clinique Dermatologique et INSERM U519, Institut Fédératif de Recherche Multidisciplinaire sur les Peptides, IFR23, Faculté Mixte de Médecine et de Pharmacie, Hopital Charles Nicolle, Rouen, France
    Dermatology 208:16-20. 2004
    ..These results have been challenged because direct immunoelectron microscopy (IEM), which was used as the standard diagnostic criterion in our initial study, does not identify the different antigens of the basement membrane zone...
  30. ncbi [Seborrheic dermatitis]
    O Chosidow
    Ann Dermatol Venereol 129:S191-3. 2002
  31. ncbi [Disulone]
    E Begon
    Service de Dermatologie du Pr Revuz, Hopital Henri Mondor, Avenue du Marechal de Lattre de Tassigny, 94000 Creteil
    Ann Dermatol Venereol 131:1062-73. 2004
    ..Despite the lack of controlled studies, the aim of this study is to specify and classify the pathological states in which disulone could be indicated...
  32. ncbi [Bullous pemphigoid in young patients: a retrospective study of 74 cases]
    E Bourdon-Lanoy
    Service de Dermatologie, , , France
    Ann Dermatol Venereol 132:115-22. 2005
    ..We also found a high frequency of pathological associations and physical treatment, all responsible for damage to the basement membrane zone, which can involve auto-immunization against hemidesmosome components...